Yayın:
Design, synthesis, and molecular docking studies of novel quinoxaline derivatives as anticancer agents

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAli, Sazan Haji
dc.contributor.authorOSMANİYE, DERYA
dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorLEVENT, SERKAN
dc.contributor.authorKAPLANCIKLI, ZAFER ASIM
dc.contributor.orcid0000-0002-5960-8067
dc.contributor.orcid0000-0002-0499-436X
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0003-3692-163X
dc.contributor.orcid0000-0001-8815-153X
dc.contributor.orcid0000-0003-2252-0923
dc.date.accessioned2025-11-13T11:02:08Z
dc.date.issued2023-04-24
dc.identifier.doihttps://doi.org/10.1111/cbdd.14246
dc.identifier.endpage315
dc.identifier.issn1747-0277
dc.identifier.issue2
dc.identifier.openalexW4366815472
dc.identifier.startpage303
dc.identifier.urihttps://hdl.handle.net/11421/6014
dc.identifier.urihttps://doi.org/10.1111/cbdd.14246
dc.identifier.volume102
dc.language.isoen
dc.relation.ispartofChemical Biology & Drug Design
dc.rightsrestrictedAccess
dc.subjectPharmacophore
dc.subjectCytotoxicity
dc.subjectChemistry
dc.subjectDocking (animal)
dc.subjectQuinoxaline
dc.subjectCombinatorial chemistry
dc.subjectT790M
dc.subjectStereochemistry
dc.subjectEpidermal growth factor receptor
dc.subjectMTT assay
dc.subjectEGFR inhibitors
dc.subjectPharmacology
dc.subjectCell growth
dc.subjectReceptor
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectIn vitro
dc.subjectOrganic chemistry
dc.subjectMedicine
dc.subjectGefitinib
dc.subject.sdg3
dc.titleDesign, synthesis, and molecular docking studies of novel quinoxaline derivatives as anticancer agents
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5028914823
local.authorid.openalexA5017640266
local.authorid.openalexA5030511747
local.authorid.openalexA5074136342
local.authorid.openalexA5075534569
local.authorid.openalexA5060247565

Dosyalar

Koleksiyonlar

Publications